Glucocorticoid receptor gene expression and promoter CpG modifications throughout the human brain.
Identifieur interne : 000618 ( Ncbi/Merge ); précédent : 000617; suivant : 000619Glucocorticoid receptor gene expression and promoter CpG modifications throughout the human brain.
Auteurs : Lei Cao-Lei [Allemagne] ; Songkiet Suwansirikul ; Prapan Jutavijittum ; Sophie B. Mériaux ; Jonathan D. Turner ; Claude P. MullerSource :
- Journal of psychiatric research [ 1879-1379 ] ; 2013.
English descriptors
- KwdEn :
- Adult, Analysis of Variance, Brain (anatomy & histology), Brain (metabolism), Dinucleoside Phosphates (genetics), Female, Gene Expression (physiology), Humans, Male, Middle Aged, Postmortem Changes, Promoter Regions, Genetic (physiology), Receptors, Glucocorticoid (metabolism), Receptors, Mineralocorticoid (genetics), Receptors, Mineralocorticoid (metabolism), Young Adult.
- MESH :
- chemical , genetics : Dinucleoside Phosphates, Receptors, Mineralocorticoid.
- anatomy & histology : Brain.
- metabolism : Brain, Receptors, Glucocorticoid, Receptors, Mineralocorticoid.
- physiology : Gene Expression, Promoter Regions, Genetic.
- Adult, Analysis of Variance, Female, Humans, Male, Middle Aged, Postmortem Changes, Young Adult.
Abstract
Glucocorticoids and the glucocorticoid (GR) and mineralocorticoid (MR) receptors have been implicated in many processes, particularly in negative feedback regulation of the hypothalamic-pituitary-adrenal axis. Epigenetically programmed GR alternative promoter usage underlies transcriptional control of GR levels, generation of GR 3' splice variants, and the overall GC response in the brain. No detailed analysis of GR first exons or GR transcript variants throughout the human brain has been reported. Therefore we investigated post mortem tissues from 28 brain regions of 5 individuals. GR first exons were expressed throughout the healthy human brain with no region-specific usage patterns. First exon levels were highly inter-correlated suggesting that they are co-regulated. GR 3' splice variants (GRα and GR-P) were equally distributed in all regions, and GRβ expression was always low. GR/MR ratios showed significant differences between the 28 tissues with the highest ratio in the pituitary gland. Modification levels of individual CpG dinucleotides, including 5-mC and 5-hmC, in promoters 1D, 1E, 1F, and 1H were low, and diffusely clustered; despite significant heterogeneity between the donors. In agreement with this clustering, sum modification levels rather than individual CpG modifications correlated with GR expression. Two-way ANOVA showed that this sum modification was both promoter and brain region specific, but that there was however no promoter*tissue interaction. The heterogeneity between donors may however hide such an interaction. In both promoters 1F and 1H modification levels correlated with GRα expression suggesting that 5-mC and 5-hmC play an important role in fine tuning GR expression levels throughout the brain.
DOI: 10.1016/j.jpsychires.2013.07.022
PubMed: 23948638
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000405
- to stream PubMed, to step Curation: 000405
- to stream PubMed, to step Checkpoint: 000405
Links to Exploration step
pubmed:23948638Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Glucocorticoid receptor gene expression and promoter CpG modifications throughout the human brain.</title><author><name sortKey="Cao Lei, Lei" sort="Cao Lei, Lei" uniqKey="Cao Lei L" first="Lei" last="Cao-Lei">Lei Cao-Lei</name><affiliation wicri:level="4"><nlm:affiliation>Institute of Immunology, Centre de Recherche Public de la Santé, Laboratoire National de Santé, 20A rue Auguste Lumière, L-1950 Luxembourg, Luxembourg; Department of Immunology, Research Institute of Psychobiology, University of Trier, D-54290 Trier, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Institute of Immunology, Centre de Recherche Public de la Santé, Laboratoire National de Santé, 20A rue Auguste Lumière, L-1950 Luxembourg, Luxembourg; Department of Immunology, Research Institute of Psychobiology, University of Trier, D-54290 Trier</wicri:regionArea><wicri:noRegion>54290 Trier</wicri:noRegion><orgName type="university">Université de Trèves</orgName><placeName><settlement type="city">Trèves (Allemagne)</settlement><region type="land" nuts="1">Rhénanie-Palatinat</region></placeName></affiliation></author><author><name sortKey="Suwansirikul, Songkiet" sort="Suwansirikul, Songkiet" uniqKey="Suwansirikul S" first="Songkiet" last="Suwansirikul">Songkiet Suwansirikul</name></author><author><name sortKey="Jutavijittum, Prapan" sort="Jutavijittum, Prapan" uniqKey="Jutavijittum P" first="Prapan" last="Jutavijittum">Prapan Jutavijittum</name></author><author><name sortKey="Meriaux, Sophie B" sort="Meriaux, Sophie B" uniqKey="Meriaux S" first="Sophie B" last="Mériaux">Sophie B. Mériaux</name></author><author><name sortKey="Turner, Jonathan D" sort="Turner, Jonathan D" uniqKey="Turner J" first="Jonathan D" last="Turner">Jonathan D. Turner</name></author><author><name sortKey="Muller, Claude P" sort="Muller, Claude P" uniqKey="Muller C" first="Claude P" last="Muller">Claude P. Muller</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23948638</idno><idno type="pmid">23948638</idno><idno type="doi">10.1016/j.jpsychires.2013.07.022</idno><idno type="wicri:Area/PubMed/Corpus">000405</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000405</idno><idno type="wicri:Area/PubMed/Curation">000405</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000405</idno><idno type="wicri:Area/PubMed/Checkpoint">000405</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000405</idno><idno type="wicri:Area/Ncbi/Merge">000618</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Glucocorticoid receptor gene expression and promoter CpG modifications throughout the human brain.</title><author><name sortKey="Cao Lei, Lei" sort="Cao Lei, Lei" uniqKey="Cao Lei L" first="Lei" last="Cao-Lei">Lei Cao-Lei</name><affiliation wicri:level="4"><nlm:affiliation>Institute of Immunology, Centre de Recherche Public de la Santé, Laboratoire National de Santé, 20A rue Auguste Lumière, L-1950 Luxembourg, Luxembourg; Department of Immunology, Research Institute of Psychobiology, University of Trier, D-54290 Trier, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Institute of Immunology, Centre de Recherche Public de la Santé, Laboratoire National de Santé, 20A rue Auguste Lumière, L-1950 Luxembourg, Luxembourg; Department of Immunology, Research Institute of Psychobiology, University of Trier, D-54290 Trier</wicri:regionArea><wicri:noRegion>54290 Trier</wicri:noRegion><orgName type="university">Université de Trèves</orgName><placeName><settlement type="city">Trèves (Allemagne)</settlement><region type="land" nuts="1">Rhénanie-Palatinat</region></placeName></affiliation></author><author><name sortKey="Suwansirikul, Songkiet" sort="Suwansirikul, Songkiet" uniqKey="Suwansirikul S" first="Songkiet" last="Suwansirikul">Songkiet Suwansirikul</name></author><author><name sortKey="Jutavijittum, Prapan" sort="Jutavijittum, Prapan" uniqKey="Jutavijittum P" first="Prapan" last="Jutavijittum">Prapan Jutavijittum</name></author><author><name sortKey="Meriaux, Sophie B" sort="Meriaux, Sophie B" uniqKey="Meriaux S" first="Sophie B" last="Mériaux">Sophie B. Mériaux</name></author><author><name sortKey="Turner, Jonathan D" sort="Turner, Jonathan D" uniqKey="Turner J" first="Jonathan D" last="Turner">Jonathan D. Turner</name></author><author><name sortKey="Muller, Claude P" sort="Muller, Claude P" uniqKey="Muller C" first="Claude P" last="Muller">Claude P. Muller</name></author></analytic><series><title level="j">Journal of psychiatric research</title><idno type="eISSN">1879-1379</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Analysis of Variance</term><term>Brain (anatomy & histology)</term><term>Brain (metabolism)</term><term>Dinucleoside Phosphates (genetics)</term><term>Female</term><term>Gene Expression (physiology)</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Postmortem Changes</term><term>Promoter Regions, Genetic (physiology)</term><term>Receptors, Glucocorticoid (metabolism)</term><term>Receptors, Mineralocorticoid (genetics)</term><term>Receptors, Mineralocorticoid (metabolism)</term><term>Young Adult</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Dinucleoside Phosphates</term><term>Receptors, Mineralocorticoid</term></keywords><keywords scheme="MESH" qualifier="anatomy & histology" xml:lang="en"><term>Brain</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Brain</term><term>Receptors, Glucocorticoid</term><term>Receptors, Mineralocorticoid</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Gene Expression</term><term>Promoter Regions, Genetic</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Analysis of Variance</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Postmortem Changes</term><term>Young Adult</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Glucocorticoids and the glucocorticoid (GR) and mineralocorticoid (MR) receptors have been implicated in many processes, particularly in negative feedback regulation of the hypothalamic-pituitary-adrenal axis. Epigenetically programmed GR alternative promoter usage underlies transcriptional control of GR levels, generation of GR 3' splice variants, and the overall GC response in the brain. No detailed analysis of GR first exons or GR transcript variants throughout the human brain has been reported. Therefore we investigated post mortem tissues from 28 brain regions of 5 individuals. GR first exons were expressed throughout the healthy human brain with no region-specific usage patterns. First exon levels were highly inter-correlated suggesting that they are co-regulated. GR 3' splice variants (GRα and GR-P) were equally distributed in all regions, and GRβ expression was always low. GR/MR ratios showed significant differences between the 28 tissues with the highest ratio in the pituitary gland. Modification levels of individual CpG dinucleotides, including 5-mC and 5-hmC, in promoters 1D, 1E, 1F, and 1H were low, and diffusely clustered; despite significant heterogeneity between the donors. In agreement with this clustering, sum modification levels rather than individual CpG modifications correlated with GR expression. Two-way ANOVA showed that this sum modification was both promoter and brain region specific, but that there was however no promoter*tissue interaction. The heterogeneity between donors may however hide such an interaction. In both promoters 1F and 1H modification levels correlated with GRα expression suggesting that 5-mC and 5-hmC play an important role in fine tuning GR expression levels throughout the brain.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23948638</PMID><DateCreated><Year>2013</Year><Month>09</Month><Day>27</Day></DateCreated><DateCompleted><Year>2014</Year><Month>05</Month><Day>13</Day></DateCompleted><DateRevised><Year>2013</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1379</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>11</Issue><PubDate><Year>2013</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of psychiatric research</Title><ISOAbbreviation>J Psychiatr Res</ISOAbbreviation></Journal><ArticleTitle>Glucocorticoid receptor gene expression and promoter CpG modifications throughout the human brain.</ArticleTitle><Pagination><MedlinePgn>1597-607</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpsychires.2013.07.022</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-3956(13)00234-3</ELocationID><Abstract><AbstractText>Glucocorticoids and the glucocorticoid (GR) and mineralocorticoid (MR) receptors have been implicated in many processes, particularly in negative feedback regulation of the hypothalamic-pituitary-adrenal axis. Epigenetically programmed GR alternative promoter usage underlies transcriptional control of GR levels, generation of GR 3' splice variants, and the overall GC response in the brain. No detailed analysis of GR first exons or GR transcript variants throughout the human brain has been reported. Therefore we investigated post mortem tissues from 28 brain regions of 5 individuals. GR first exons were expressed throughout the healthy human brain with no region-specific usage patterns. First exon levels were highly inter-correlated suggesting that they are co-regulated. GR 3' splice variants (GRα and GR-P) were equally distributed in all regions, and GRβ expression was always low. GR/MR ratios showed significant differences between the 28 tissues with the highest ratio in the pituitary gland. Modification levels of individual CpG dinucleotides, including 5-mC and 5-hmC, in promoters 1D, 1E, 1F, and 1H were low, and diffusely clustered; despite significant heterogeneity between the donors. In agreement with this clustering, sum modification levels rather than individual CpG modifications correlated with GR expression. Two-way ANOVA showed that this sum modification was both promoter and brain region specific, but that there was however no promoter*tissue interaction. The heterogeneity between donors may however hide such an interaction. In both promoters 1F and 1H modification levels correlated with GRα expression suggesting that 5-mC and 5-hmC play an important role in fine tuning GR expression levels throughout the brain.</AbstractText><CopyrightInformation>Copyright © 2013 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cao-Lei</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Immunology, Centre de Recherche Public de la Santé, Laboratoire National de Santé, 20A rue Auguste Lumière, L-1950 Luxembourg, Luxembourg; Department of Immunology, Research Institute of Psychobiology, University of Trier, D-54290 Trier, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suwansirikul</LastName><ForeName>Songkiet</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Jutavijittum</LastName><ForeName>Prapan</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Mériaux</LastName><ForeName>Sophie B</ForeName><Initials>SB</Initials></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Jonathan D</ForeName><Initials>JD</Initials></Author><Author ValidYN="Y"><LastName>Muller</LastName><ForeName>Claude P</ForeName><Initials>CP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Psychiatr Res</MedlineTA><NlmUniqueID>0376331</NlmUniqueID><ISSNLinking>0022-3956</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015226">Dinucleoside Phosphates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011965">Receptors, Glucocorticoid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018161">Receptors, Mineralocorticoid</NameOfSubstance></Chemical><Chemical><RegistryNumber>2382-65-2</RegistryNumber><NameOfSubstance UI="C015772">cytidylyl-3'-5'-guanosine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000033" MajorTopicYN="N">anatomy & histology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015226" MajorTopicYN="N">Dinucleoside Phosphates</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011180" MajorTopicYN="N">Postmortem Changes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011965" MajorTopicYN="N">Receptors, Glucocorticoid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018161" MajorTopicYN="N">Receptors, Mineralocorticoid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CAS (l)</Keyword><Keyword MajorTopicYN="N">CAS (u)</Keyword><Keyword MajorTopicYN="N">CG</Keyword><Keyword MajorTopicYN="N">CN</Keyword><Keyword MajorTopicYN="N">Cb</Keyword><Keyword MajorTopicYN="N">DG</Keyword><Keyword MajorTopicYN="N">GC</Keyword><Keyword MajorTopicYN="N">GP</Keyword><Keyword MajorTopicYN="N">GR</Keyword><Keyword MajorTopicYN="N">GR 3′ splice variants</Keyword><Keyword MajorTopicYN="N">GR first exon transcripts</Keyword><Keyword MajorTopicYN="N">Glucocorticoid receptors</Keyword><Keyword MajorTopicYN="N">Hi(CA1-3)</Keyword><Keyword MajorTopicYN="N">Hi(CA4)</Keyword><Keyword MajorTopicYN="N">Human brain</Keyword><Keyword MajorTopicYN="N">IFG</Keyword><Keyword MajorTopicYN="N">ITG</Keyword><Keyword MajorTopicYN="N">LC</Keyword><Keyword MajorTopicYN="N">MFG</Keyword><Keyword MajorTopicYN="N">MR</Keyword><Keyword MajorTopicYN="N">MTG</Keyword><Keyword MajorTopicYN="N">Methylation status</Keyword><Keyword MajorTopicYN="N">Mineralocorticoid receptors</Keyword><Keyword MajorTopicYN="N">NA</Keyword><Keyword MajorTopicYN="N">PG</Keyword><Keyword MajorTopicYN="N">PHG</Keyword><Keyword MajorTopicYN="N">PVN</Keyword><Keyword MajorTopicYN="N">Pit</Keyword><Keyword MajorTopicYN="N">Put</Keyword><Keyword MajorTopicYN="N">SFG</Keyword><Keyword MajorTopicYN="N">SN</Keyword><Keyword MajorTopicYN="N">SOG</Keyword><Keyword MajorTopicYN="N">SPG</Keyword><Keyword MajorTopicYN="N">SUBv-sp</Keyword><Keyword MajorTopicYN="N">VMHvl</Keyword><Keyword MajorTopicYN="N">WM</Keyword><Keyword MajorTopicYN="N">amg</Keyword><Keyword MajorTopicYN="N">amygdala</Keyword><Keyword MajorTopicYN="N">caudate nucleus</Keyword><Keyword MajorTopicYN="N">cerebellum</Keyword><Keyword MajorTopicYN="N">cingulate gyrus</Keyword><Keyword MajorTopicYN="N">cornu ammonis of the hippocampus subregions 1-3</Keyword><Keyword MajorTopicYN="N">cornu ammonis of the hippocampus subregions 4</Keyword><Keyword MajorTopicYN="N">dentate gyrus</Keyword><Keyword MajorTopicYN="N">globus pallidus</Keyword><Keyword MajorTopicYN="N">glucocorticoid</Keyword><Keyword MajorTopicYN="N">glucocorticoid receptor</Keyword><Keyword MajorTopicYN="N">inferior frontal gyrus</Keyword><Keyword MajorTopicYN="N">inferior temporal gyrus</Keyword><Keyword MajorTopicYN="N">locus coeruleus</Keyword><Keyword MajorTopicYN="N">lower bank of the calcarine sulcus</Keyword><Keyword MajorTopicYN="N">middle frontal gyrus</Keyword><Keyword MajorTopicYN="N">middle temporal gyrus</Keyword><Keyword MajorTopicYN="N">mineralocorticoid receptor</Keyword><Keyword MajorTopicYN="N">nucleus accumbens</Keyword><Keyword MajorTopicYN="N">parahypocampal gyrus</Keyword><Keyword MajorTopicYN="N">paraventricular nucleus</Keyword><Keyword MajorTopicYN="N">pineal gland</Keyword><Keyword MajorTopicYN="N">pituitary gland</Keyword><Keyword MajorTopicYN="N">putamen</Keyword><Keyword MajorTopicYN="N">substantia nigra</Keyword><Keyword MajorTopicYN="N">superior frontal gyrus</Keyword><Keyword MajorTopicYN="N">superior occipital gyrus</Keyword><Keyword MajorTopicYN="N">superior parietal gyrus</Keyword><Keyword MajorTopicYN="N">upper bank of the calcarine sulcus</Keyword><Keyword MajorTopicYN="N">ventral subiculum pyramidal layer</Keyword><Keyword MajorTopicYN="N">ventromedial hypothalamus (ventrolateral)</Keyword><Keyword MajorTopicYN="N">white matter</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>02</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>07</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>07</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23948638</ArticleId><ArticleId IdType="pii">S0022-3956(13)00234-3</ArticleId><ArticleId IdType="doi">10.1016/j.jpsychires.2013.07.022</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li></country><region><li>Rhénanie-Palatinat</li></region><settlement><li>Trèves (Allemagne)</li></settlement><orgName><li>Université de Trèves</li></orgName></list><tree><noCountry><name sortKey="Jutavijittum, Prapan" sort="Jutavijittum, Prapan" uniqKey="Jutavijittum P" first="Prapan" last="Jutavijittum">Prapan Jutavijittum</name><name sortKey="Meriaux, Sophie B" sort="Meriaux, Sophie B" uniqKey="Meriaux S" first="Sophie B" last="Mériaux">Sophie B. Mériaux</name><name sortKey="Muller, Claude P" sort="Muller, Claude P" uniqKey="Muller C" first="Claude P" last="Muller">Claude P. Muller</name><name sortKey="Suwansirikul, Songkiet" sort="Suwansirikul, Songkiet" uniqKey="Suwansirikul S" first="Songkiet" last="Suwansirikul">Songkiet Suwansirikul</name><name sortKey="Turner, Jonathan D" sort="Turner, Jonathan D" uniqKey="Turner J" first="Jonathan D" last="Turner">Jonathan D. Turner</name></noCountry><country name="Allemagne"><region name="Rhénanie-Palatinat"><name sortKey="Cao Lei, Lei" sort="Cao Lei, Lei" uniqKey="Cao Lei L" first="Lei" last="Cao-Lei">Lei Cao-Lei</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Rhénanie/explor/UnivTrevesV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000618 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000618 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Rhénanie
|area= UnivTrevesV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:23948638
|texte= Glucocorticoid receptor gene expression and promoter CpG modifications throughout the human brain.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:23948638" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a UnivTrevesV1
| This area was generated with Dilib version V0.6.31. |  |